News

Master of Health Administration (MHA) students recently had the opportunity to speak with J. Stephen Jones, president and CEO of Inova Health System, one of Virginia’s largest hospital systems. Jones shared his leadership philosophy and advice with MHA students as part of the HAP 704 Executive Speaker Series, where students meet highly-respected leaders in the industry.

Jessica Lammers, who will graduate with her master of public health on Dec. 16, found a job as an environmental health specialist with Fairfax County through her internship.

Amria Roess, professor in the Department of Global and Community Health, answers frequently asked questions relating to the new COVID-19 Omicron variant.

Amira Roess, professor of global health and epidemiology at Mason’s College of Health and Human Services, and Angela Chezem, MD, medical director, COVID Surveillance Program (Safety, Emergency, and Enterprise Risk Management), offer advice to the Mason community on omicron variant safety over the winter holiday season.

I'm a Virus Expert and Here's a Sure Sign You've Had COVID. 

I'm a Virus Expert and Here's a Sure Sign You've Had COVID. 

Emergence of the COVID-19 omicron variant in US. Roess starts at the 20-second mark.

Members of the Master of Social Work Student Association (MSWSA) honored survivors of domestic violence during National Domestic Violence Awareness Month by organizing a donation drive competition. The month-long college-wide donation drive collected approximately 357 items across the College of Health and Human Service’s (CHHS) five departments, a testament to the CHHS community’s commitment to helping those in need.

Patricia Tran became interested in health informatics while working as a nurse. She is now pursuing a Master of Health Informatics degree at Mason, where she obtained an internship with Commonwealth Cyber Initiative (CCI) over the summer to research how 5G-enabled technology can transform telehealth care.

A holiday gift that no one wants: More weight.

In a recent study, George Mason University Associate Professor Hong Xue, PhD and colleagues evaluated the impact of ending market exclusivity for brand-name statin drugs. The first study to comprehensively assess the economic impact of generic competition for statins found that ending market exclusivity for statins saves U.S. $12 billion and individuals nearly $1,000 annually.